Oncology

Key takeaways

• Meta-analysis synthesized 11 randomized controlled trials comprising 548 adult cancer patients undergoing neurotoxic chemotherapy.
• Sensorimotor training was associated with significant reductions in patient-reported (SMD 0.54) and clinician-graded (SMD 0.50) neuropathy symptoms.
• Interventions yielded substantial functional gains in postural balance (SMD 0.79) and lower-extremity muscle strength (SMD 0.67).
• Overall evidence certainty was evaluated as low per GRADE criteria due to small sample sizes, study heterogeneity, and risk of bias.

Nursing implications

• Screen patients receiving neurotoxic chemotherapy for numbness, paresthesias, and unsteady gait; provide early fall prevention education and collaborate with oncology physical therapy to initiate guided sensorimotor and balance exercises per facility care pathways.

Limitations & cautions

• Low certainty of evidence across outcomes per GRADE; small sample sizes across primary studies; heterogeneous training protocols and variable chemotherapy regimens precluded definitive dosing recommendations.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Partially randomized patient-preference trial enrolled 587 distressed cancer survivors across multiple tumor types and disease stages.
• Both mindfulness (MBCR) and movement-based Tai Chi (TCQ) produced statistically significant improvements in cancer-related fatigue (P = .036 and P = .043).
• Both interventions achieved meaningful reductions of greater than 1 point in chronic pain interference (P = .029 and P = .002).
• Tai Chi uniquely achieved a statistically significant 1.9-point improvement in overall sleep quality scale scores (P = .004).

Nursing implications

• Screen cancer survivors routinely for clustered symptoms of fatigue, pain, and insomnia, and discuss evidence-backed integrative referrals such as mindfulness-based recovery or Tai Chi as non-pharmacological adjuncts to symptom management.

Limitations & cautions

• Partially randomized design allowed patient preference selection; waitlist comparison group rather than active sham control; symptom endpoints relied on patient-reported validated scales.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Multicenter randomized trial in 18 French ICUs evaluated transfusion thresholds during initial 48 hours of septic shock in cancer patients.
• Trial halted prematurely at 187 patients due to safety imbalances between study arms.
• Liberal transfusion (Hb < 9.0 g/dL) failed to improve 12-hour lactate clearance (52% vs 50%, P = 0.82) or 28-day mortality (46% vs 53%, P = 0.34).
• Liberal transfusion was associated with a marked increase in arterial and venous thrombotic events (13% vs 1%, P = 0.001).

Nursing implications

• Adhere strictly to restrictive transfusion thresholds (hemoglobin < 7.0 g/dL) during septic shock resuscitation unless provider orders or institutional protocol dictate otherwise, and maintain heightened surveillance for deep vein thrombosis or arterial occlusion if liberal transfusions are administered.

Limitations & cautions

• Premature termination resulted in underpowered final sample size (187 enrolled of 260 planned); conducted exclusively within French intensive care units; limited to adult hematologic and solid oncology patients.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Systematic review synthesized 14 clinical studies evaluating nurse-led predictive symptom management protocols in oncology palliative care.
• Laboratory biomarkers including CRP, neutrophil-lymphocyte ratio (NLR), albumin, ferritin, and electrolytes reliably heralded impending clinical decline.
• Nurse-coordinated integration of biomarker trends with structured clinical assessment shifted care from reactive firefighting to proactive symptom stabilization.
• Predictive nursing models were associated with reduced emergency department admissions and improved symptom-related quality of life.

Nursing implications

• Review trending laboratory indicators (such as rising CRP, worsening NLR, or falling albumin) during oncology and palliative encounters as early alert signals for impending symptom crisis or disease progression, adjusting supportive care plans and symptom titration before severe functional decline develops.

Limitations & cautions

• Heterogeneity in study designs, biomarker panels, and tumor types across the 14 included studies; algorithms and predictive models require standardized electronic health record integration before universal bedside adoption.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Tunnelled PICCs reduced the risk of catheter-related postoperative infection by 63% (OR 0.37; 95% CI 0.27-0.51) in oncologic patients.
• Symptomatic catheter-related venous thrombosis was reduced by 68% (OR 0.32; 95% CI 0.22-0.47) compared with conventional lines.
• Catheter dislodgement decreased by 50% (OR 0.50) and unplanned extubation by 55% (OR 0.45), supporting catheter longevity throughout chemotherapy.
• First-attempt puncture success improved (OR 2.53), while exit-site oozing at 24 hours was cut by more than half (OR 0.41).

Nursing implications

• When caring for cancer patients with tunnelled PICCs, assess the subcutaneous tunnel tract and exit site for erythema, induration, or tenderness during every shift. Maintain strict chlorhexidine dressing change technique, enforce securement device protocols, and flush lumens per unit vascular access policy.

Limitations & cautions

• The majority of included studies originated from single-country specialized centers, catheter tunnelling remains off-label in some regions, and operator experience varied across trial institutions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• ERAS pathways reduced postoperative surgical complications by 40% (RR 0.60) and decreased perioperative mortality (RR 0.33).
• Cancer patients in ERAS programs demonstrated improved long-term overall survival (HR 0.68) and disease-free survival (HR 0.63).
• Patients reported significantly reduced pain on postoperative day 1 (SMD -1.00) and day 3 (SMD -0.83), accompanied by improved quality of life (SMD 0.69).
• Mean hospital length of stay decreased by 2.72 days, while hospitalization expenses were measurably lower compared with conventional care.

Nursing implications

• Reinforce pre- and postoperative patient education, prioritize multimodal non-opioid pain strategies to maintain bowel motility, and facilitate structured early mobilization on postoperative day 1 according to unit protocol. Monitor inflammatory markers and nutritional recovery indicators throughout the acute admission.

Limitations & cautions

• A majority of included clinical trials originated from Chinese healthcare centers, and reductions in hospital stay were not statistically significant among elderly sub-cohorts or in high-income countries with already shortened baseline admissions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Home-based exercise significantly enhanced cardiorespiratory fitness (SMD 0.42; 95% CI 0.09-0.75) and quality of life (SMD 0.63; 95% CI 0.05-1.22).
• Program adherence exceeded 75% across most trials evaluating participation, with an overall dropout rate of 15.2%.
• Safety outcomes and adverse events were inconsistently reported across studies, and effects on muscle strength and fatigue remained variable.
• The authors emphasized that home programs provide an accessible alternative or adjunct when center-based rehabilitation is unavailable.

Nursing implications

• Screen oncology patients for cardiovascular risk factors and fatigue, reinforce provider-cleared home activity goals, and educate patients on exertion pacing and warning symptoms. Emphasize gradual progression and coordinate with physical therapy or cardio-oncology rehabilitation services per institutional protocol.

Limitations & cautions

• The meta-analysis included nine trials with 632 participants and notable statistical heterogeneity for quality of life (I² = 84%). Incomplete adverse-event reporting limits definitive safety conclusions, and the trials primarily evaluated exercise components rather than comprehensive multidisciplinary cardiac rehab.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Older age was associated with lower odds of ovarian function recovery, with a pooled odds ratio of 0.25.
• Longer chemotherapy duration was also associated with lower recovery odds, with a pooled odds ratio of 0.68.
• Pretreatment anti-Müllerian hormone appeared favorable in individual studies, but the pooled association was not statistically significant.

Nursing implications

• Ask about reproductive goals before treatment when appropriate, document concerns, and route timely referrals through the oncology team's fertility-preservation pathway. Present recovery estimates as pooled probabilities rather than predictions for an individual patient.

Limitations & cautions

• The studies varied in populations, treatments, and definitions of ovarian recovery. Confidence intervals were wide, especially at 60 months, and the abstract does not establish which fertility-preservation strategy is best for an individual patient.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Lung and pancreatic adenocarcinomas were the histologic subtypes most frequently associated with cancer-related coagulopathy stroke.
• Multiple infarcts across more than two vascular territories were a characteristic imaging pattern described in the review.
• Low-molecular-weight heparin and direct oral anticoagulants were commonly used for secondary prevention, but the review did not establish one optimal antithrombotic strategy.

Nursing implications

• Treat any new focal neurologic deficit as an emergency, document onset and progression precisely, and promptly communicate active or metastatic cancer, recent cancer diagnosis, coagulation results, and current antithrombotic therapy to the stroke team. Follow facility stroke and anticoagulation protocols and provider orders.

Limitations & cautions

• The review synthesized heterogeneous studies qualitatively and did not report a pooled treatment comparison. Biomarkers other than D-dimer had limited specificity, and the abstract does not support choosing one anticoagulant or screening strategy.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Financial toxicity accumulated from medical expenses, indirect costs, employment disruption, and inadequate insurance or social support.
• The burden extended beyond treatment and affected household stability, living standards, and psychosocial wellbeing.
• Families used financial assistance and major changes to work and daily life, but these strategies often did not fully relieve the burden.

Nursing implications

• Ask families whether treatment-related costs, travel, missed work, or access to basic needs are creating difficulty, document the concern, and connect them with the oncology social worker, financial navigator, or other approved support pathway early.

Limitations & cautions

• This was a qualitative synthesis rather than an intervention study, so it does not estimate prevalence or prove that a specific support program improves outcomes. Most participants were parents, and experiences may differ across health systems and family structures.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Early palliative care was defined as starting within 12 weeks of diagnosis or first-line treatment while usual cancer care continued.
• Quality of life improved with low between-study heterogeneity across 39 trials involving 8,399 adults.
• The overall-survival finding was exploratory and should not be presented as a guaranteed survival benefit.

Nursing implications

• Screen for symptom, psychosocial, communication, and caregiver-support needs early in treatment, explain that palliative care can occur alongside disease-directed therapy, and route unmet needs through the oncology team's approved referral pathway.

Limitations & cautions

• Abstract-only summary. The review pooled different cancers and palliative-care models, most trials came from North America or Europe, and the reported overall-survival benefit was exploratory. The abstract did not report pooled depression or symptom-burden estimates.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Sleep-quality and depression scores were better with true self-acupressure than with both comparison groups at the end of treatment and follow-up.
• Fatigue was lower than usual care at both time points, but the difference from sham acupressure was statistically significant only at follow-up.
• Quality of life was better than usual care at both time points, while the difference from sham acupressure was not statistically significant immediately after treatment.

Nursing implications

• Assess fatigue, sleep, mood, and quality-of-life concerns together and escalate significant or worsening symptoms through the survivorship pathway. If self-acupressure is available within an approved supportive-care plan, present it as an adjunct rather than a replacement for evaluation or treatment.

Limitations & cautions

• This was a small trial with 108 randomized participants and 93 completers. Some outcomes did not differ from sham treatment immediately after the intervention, clinical effect sizes were not reported in the abstract, and cost-effectiveness remains unknown.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 709 children with high-risk B-cell ALL after consolidation to two cycles of blinatumomab or two cycles of chemotherapy.
• At a median 2.9 years of follow-up, estimated four-year event-free survival was 83.0% with blinatumomab versus 70.3% with chemotherapy.
• Treatment-related infection occurred in 23.9% versus 69.4%, while neurotoxic events occurred in 12.0% versus 3.2%; grade 2 or higher cytokine release syndrome occurred in 1.1% with blinatumomab.

Nursing implications

• When caring for a child receiving protocol-directed blinatumomab, verify the treatment phase and infusion plan, perform ordered neurologic and cytokine-release-syndrome assessments, and escalate fever, neurologic change, or infusion interruption through the pediatric oncology pathway. Do not substitute this regimen outside the treating team's protocol.

Limitations & cautions

• Abstract-only summary of a planned interim analysis with median follow-up of 2.9 years. The primary outcome estimate was four-year event-free survival rather than mature overall survival, and the findings apply to the trial's newly diagnosed high-risk B-cell ALL population and protocol.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial enrolled patients with at least one adenoma 10 mm or larger, high-grade dysplasia or villous growth, or 3 to 10 adenomas.
• The upper boundary of the one-sided 99.12% confidence interval was 0.68 percentage points, below the prespecified 0.7-point noninferiority margin.
• This was a 5.5-year interim analysis of an ongoing 10-year trial; five colorectal cancer deaths had occurred across both groups.

Nursing implications

• Confirm the documented pathology, recommended surveillance interval, and responsible follow-up clinician at transition points. Reinforce the prescribed preparation and scheduling plan, and route overdue or conflicting recommendations to the gastroenterology team rather than changing the interval independently.

Limitations & cautions

• Abstract-only summary of an interim analysis. The final primary endpoint is colorectal cancer incidence at 10 years, inverse-probability weighting addressed missing surveillance data, and the enrolled European high-risk-adenoma population may not represent every surveillance setting.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Multidisciplinary evaluation is encouraged for all patients with bladder cancer being considered for radiation therapy.
• The guideline recommends intensity-modulated radiation therapy with daily image guidance and provides target-coverage and normal-tissue dose guidance.
• Adjuvant radiation is conditionally recommended for selected high-risk pathologic findings after cystectomy, while bladder-directed radiation is recommended for local control or palliation in selected noncurative settings.

Nursing implications

• Verify the documented treatment intent and concurrent systemic-therapy plan, reinforce the radiation-oncology team's preparation and monitoring instructions, and escalate treatment concerns through the local oncology pathway.

Limitations & cautions

• Abstract-only summary. The abstract reports selected recommendations but not the full evidence tables, recommendation grades, dose details, contraindications, or patient-selection criteria; clinicians should consult the complete guideline.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Prehabilitation reduced the incidence of urinary incontinence at one and six months after surgery, with no significant difference at 12 months.
• The analysis found no significant improvement in incontinence severity or erectile function at any assessed follow-up point.
• Quality of life improved within three and six months, while the estimate within 12 months did not reach statistical significance.

Nursing implications

• Reinforce the individualized preoperative exercise or pelvic-floor plan ordered by the surgical team, assess the patient's ability to perform it, and use teach-back for postoperative continence tracking and follow-up. Follow the local perioperative protocol for restrictions and escalation.

Limitations & cautions

• Abstract-only summary. Risk of bias was generally moderate, interventions varied across 16 trials, and benefits for several outcomes were absent or no longer statistically significant at later follow-up.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The pooled anxiety estimate favored eHealth interventions, but heterogeneity was high and certainty was very low.
• Quality of life did not improve significantly in the pooled analysis.
• The post-traumatic stress estimate was not stable in sensitivity analysis.

Nursing implications

• Screen caregiver distress within the established oncology pathway, explain available digital support without presenting it as a replacement for clinical care, and escalate urgent mental-health concerns through local protocols.

Limitations & cautions

• Abstract-only summary. Evidence certainty was moderate only for depression and very low for anxiety, quality of life, and post-traumatic stress symptoms; intervention reporting and follow-up also varied.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Chemotherapy was the treatment factor most consistently associated with prolonged sick leave, delayed return to work, and reduced work ability.
• Radical surgery and axillary lymph node dissection were associated with delayed return to work because of physical sequelae.
• Depression, anxiety, and low self-efficacy appeared to be additional psychosocial factors that could complicate occupational recovery.

Nursing implications

• During survivorship care, document treatment-related functional concerns and patient-reported barriers to work, and route rehabilitation or psychosocial needs through the established oncology care plan.

Limitations & cautions

• Abstract-only summary. The review used a narrative synthesis of studies with varied designs and settings, so the reported relationships are associations and do not establish that a specific treatment caused an individual work outcome.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The original 24-month analysis did not meet the trial's primary progression-free-survival endpoint.
• Pyrexia was the most common treatment-related adverse event, reported in 65.9% with spartalizumab and 46.2% with placebo.
• Grade 3 or higher treatment-related adverse events occurred in 57.3% versus 36.7%, respectively.

Nursing implications

• For patients receiving these therapies, monitor and escalate fever and other treatment toxicities according to the oncology regimen, provider orders, and local protocol.

Limitations & cautions

• Abstract-only summary. This is a final secondary overall-survival analysis after the trial failed its primary progression-free-survival endpoint; the abstract provides limited detail on individual serious toxicities or subsequent therapy.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The search included nursing and ostomy-specific organizations as well as guideline and evidence databases.
• At least two trained reviewers independently assessed literature quality before extraction and synthesis.
• The abstract describes the four support domains but does not report patient outcomes or effect estimates for specific interventions.

Nursing implications

• Before discharge, assess whether the caregiver's skills, care-process support, wellbeing, and follow-up resources have been addressed under the local ostomy pathway.

Limitations & cautions

• Abstract-only summary. The synthesis combined multiple evidence types with professional opinion, and the abstract does not provide the individual evidence statements, certainty ratings, or outcome effects.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The intervention was designed around family caregivers' supportive-care needs.
• All four measured need domains favored the smartphone-education group at four weeks.
• The abstract reports statistical significance but does not provide effect sizes or describe the educational content in detail.

Nursing implications

• Assess what caregivers still need to know and use approved digital education as a supplement to individualized teaching and follow-up.

Limitations & cautions

• Abstract-only summary. The trial included 80 caregivers at two hospitals, assessed self-reported needs after only four weeks, and did not report patient outcomes or effect sizes in the abstract.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Grade 3 or higher infection occurred in 28% versus 41%, respectively.
• Grade 3 or higher hemorrhage occurred in 2% versus 12%, respectively.

Nursing implications

• Reinforce the individualized oncology plan and communicate infection or bleeding concerns promptly.

Limitations & cautions

• Abstract-only summary of an industry-funded phase 2 trial. Core-binding-factor fusions, FLT3 mutations, and NPM1 mutations in patients under 60 were excluded. Event-free survival is not overall survival.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The post hoc analysis included 264 women from a randomized trial of app-based symptom and adherence monitoring.
• Higher baseline symptom-management self-efficacy was associated with lower symptom burden and greater odds of endocrine-therapy adherence.
• The tailored-feedback intervention showed its largest estimated adherence benefit at lower self-efficacy levels.
• The low-self-efficacy estimate had a wide confidence interval, and effects diminished and became nonsignificant at higher self-efficacy levels.

Nursing implications

• Ask how confident the patient feels managing symptoms and the daily regimen, then assess barriers, symptom burden, missed doses, and support preferences. Route concerns through the survivorship or oncology pathway and use remote monitoring only within the approved program.

Limitations & cautions

• This was a post hoc effect-modification analysis rather than a prespecified primary comparison. Adherence was recorded with a connected pillbox, the low-self-efficacy estimate was imprecise, and the findings do not establish that the same intervention will work in other populations or platforms.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 698 patients with active cancer and suspected acute pulmonary embolism.
• A YEARS strategy using clinical items, D-dimer, and risk-dependent CTPA met the prespecified noninferiority criterion.
• The YEARS pathway avoided immediate CTPA in 77 of 352 patients, or 22%.
• The proportion of negative CTPA results did not differ significantly between groups.

Nursing implications

• Recognize and escalate possible PE promptly, collect the clinical information and ordered D-dimer needed for the approved pathway, and verify whether the organization permits YEARS in active cancer. Do not use the trial to independently rule out PE or defer imaging outside protocol.

Limitations & cautions

• The study was open label, applied a prespecified noninferiority margin, and was conducted in 21 European hospitals. The result supports the tested pathway in eligible patients but does not validate unsupervised bedside use or every cancer population.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The open-label single-center trial randomized 60 neutropenic adults entering protective isolation.
• Anxiety decreased more after virtual reality hypnosis than after the control activity.
• Pain ratings were below 2 and did not differ between groups.
• Scorable anxiety data fell from 58 participants on day one to 30 on day three.

Nursing implications

• Assess anxiety, symptoms, device tolerance, and contraindications before use; maintain all protective-isolation precautions during the session; and reassess distress afterward while continuing the broader supportive-care plan.

Limitations & cautions

• The study was open label, single center, and small. The number of participants with scorable anxiety data declined across the three days, pain was minimal at baseline, and the results do not establish durability or generalizability.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review pooled 19 randomized trials with 1,527 breast cancer surgery patients.
• Postoperative morphine use and pain scores were comparable between the two regional-block techniques.
• Postoperative nausea and vomiting, fentanyl use, rescue analgesia, and analgesia duration were also comparable.
• The findings do not establish that one block is superior for postoperative analgesia.

Nursing implications

• Identify which block the patient received, trend pain at rest and with movement, document rescue analgesia and nausea, and escalate inadequate control or unexpected deterioration through the perioperative team’s pathway.

Limitations & cautions

• The abstract reports pooled comparisons but does not describe heterogeneity, certainty of evidence, or complication rates in detail. Choice of block remains a procedural decision based on patient factors, clinician expertise, and local practice.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Only 201 of 489 induction-phase participants met response, disease-distribution, and resectability criteria and were randomized.
• Median time to treatment failure was 20.4 months with resection versus 11.8 months with maintenance therapy.
• Grade 3-4 treatment-related adverse events occurred in 39% of assessed surgery-group patients and 21% of maintenance-group patients.
• Two treatment-related deaths occurred in the surgery group; the trial remains ongoing and overall survival was not the reported primary endpoint.

Nursing implications

• Verify the treatment phase and planned timing of therapy around surgery, monitor ordered liver-function, platelet, and urine-protein measures plus the postoperative assessment, and escalate abnormalities through the oncology-surgical pathway. Do not generalize this strategy to patients who did not meet the trial's selection criteria.

Limitations & cautions

• The open-label trial enrolled patients at 24 hospitals in China and randomized only selected responders without extrahepatic metastasis who were considered resectable. Follow-up was 18.4 months, the primary endpoint was time to treatment failure rather than overall survival, and the study was funded in part by the drug manufacturer.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 10 controlled studies of follow-up after an abnormal FIT or fecal occult blood test in health-disparity populations.
• Eight studies evaluated patient navigation, which increased colonoscopy completion versus usual care with a pooled risk ratio of 1.27.
• The navigation result was rated moderate certainty and remained stable across the review's registered pooled analyses.
• Evidence for registry-based quality improvement and low-touch result notification came from one study each.

Nursing implications

• At result communication or transition of care, verify that the patient understands the need for diagnostic colonoscopy, who will arrange it, and how preparation or transportation barriers will be addressed. Track open referrals according to the organization's follow-up process rather than treating an abnormal screening result as a closed task.

Limitations & cautions

• Interventions and follow-up intervals varied, relatively few studies informed each intervention type, and detection data were sparse. The review supports navigation for completion, but it does not identify one universally effective navigation model or establish effects on cancer stage or mortality.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• BRCA1/2 carriers with open family planning began with greater decisional conflict than those who had completed family planning.
• Decision coaching combined an in-person session with a structured, evidence-based aid describing preventive options.
• Among initially undecided participants with open family planning, more reached a preventive decision by 12 weeks with coaching than with usual care.
• The analysis was exploratory and assessed decision process outcomes, not cancer incidence, survival, or the clinical superiority of any option.

Nursing implications

• Clarify what the patient understands about each option, ask how family-planning goals affect timing, and connect unresolved questions to genetics, oncology, gynecology, or fertility specialists through the established pathway. Document preferences and uncertainty without presenting decision completion as consent for a specific intervention.

Limitations & cautions

• This was an exploratory subgroup analysis of a randomized trial, and the abstract does not report subgroup size or long-term clinical outcomes. Reaching a decision does not establish that the decision was durable, preferred later, or medically superior.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 150 consecutive patients to 22-gauge fine-needle biopsy or 19-gauge fine-needle aspiration during EBUS-TBNA.
• Overall diagnostic yield did not differ significantly between the two needle strategies.
• Fine-needle biopsy produced adequate tissue in 98.6% of procedures versus 86.7% with aspiration and yielded larger tissue cores.
• The reported advantage in histologic diagnostic yield came from a post hoc analysis, and minor bleeding was the only reported tolerability issue.

Nursing implications

• For EBUS-TBNA, confirm the planned needle and specimen workflow during the procedural pause, protect labeling and handoff accuracy, and monitor for bleeding in recovery. Present the tissue-adequacy result separately from the unchanged primary diagnostic-yield result when discussing the evidence with the team.

Limitations & cautions

• This was a single-center trial, compared needles of different gauges and designs, and did not show a significant difference in its primary diagnostic-yield outcome. The histologic-yield finding was post hoc, so it cannot establish superiority without confirmation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 120 patients undergoing transoral endoscopic thyroidectomy via the vestibular approach, with 60 participants per group.
• At day seven, the rehabilitation group had greater cervical mobility in six directions and lower neck pain and disability scores.
• At one month, illness-perception, quality-of-life, and nursing-satisfaction measures favored the rehabilitation group.
• Drainage volume, drain duration, hospital stay, and the incidence of reported postoperative adverse events did not differ between groups.

Nursing implications

• When early exercise is included in the postoperative pathway, verify readiness and movement restrictions, assess baseline pain and neck mobility, teach the prescribed range and frequency, and document tolerance and progress. Stop and escalate airway symptoms, new swelling, bleeding, neurologic symptoms, severe pain, or other postoperative concerns.

Limitations & cautions

• The intervention combined evidence-based rehabilitation nursing with exercises, so the effect of either component cannot be separated. Follow-up was one month, the abstract does not describe blinding, and the findings apply specifically to transoral endoscopic thyroidectomy via the vestibular approach.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The open-label trial randomized 127 children aged 3 to 18 years receiving high-dose methotrexate for acute lymphoblastic leukemia.
• The primary per-protocol analysis included 118 participants with available day-14 outcomes.
• Any-grade and grade II or worse oral mucositis were less frequent with ice-cold saline rinses than with standard oral care alone.
• Mucositis duration did not differ significantly, and no serious oral-cryotherapy-related adverse events were reported.

Nursing implications

• If oral cryotherapy is ordered in the treatment plan, verify timing and technique, assess developmental ability and aspiration risk, monitor tolerance and oral findings, and continue the standard oral-care bundle. Escalate pain, reduced intake, bleeding, ulceration, fever, or suspected infection.

Limitations & cautions

• This was a single-center, open-label trial with a per-protocol primary analysis that excluded nine randomized participants, seven from the cryotherapy group. The subgroup findings were exploratory, and multicenter confirmation with intention-to-treat analysis is needed before routine implementation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 271 patients after physician-verified suspicion of colorectal cancer, with 222 included as complete cases.
• Self-efficacy increased by an estimated 6.98 points with navigation and 2.06 points with standard care.
• The estimated between-group difference in change was 4.92 points, with a 95% confidence interval from 0.75 to 9.08.
• The intervention combined needs assessment, distress evaluation, and emotional support from diagnosis through treatment completion or follow-up.

Nursing implications

• Use an approved navigation pathway to identify practical and emotional needs, document distress and unresolved barriers, coordinate referrals, and close the loop across treatment transitions. Track patient understanding and confidence rather than assuming that information alone resolves navigation needs.

Limitations & cautions

• Only 222 of 271 randomized participants were included as complete cases, and the abstract reports the self-efficacy outcome without clinical-event, quality-of-life, utilization, or long-term durability results. The intervention was delivered by specially educated navigators, so effects may depend on training and local service design.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The secondary analysis included 518 patients from the multicenter randomized PHYSSURG-C trial.
• The intervention used additional unsupervised moderate physical activity for two weeks before and four weeks after colorectal-cancer surgery.
• The four-week intention-to-treat fatigue difference was 3.75 points, with a 95% confidence interval from 0.01 to 7.49.
• Quality of life, pain, and mental recovery did not differ, and the fatigue analysis was post hoc and exploratory.

Nursing implications

• Assess baseline mobility, fatigue, symptoms, fall risk, nutrition, and barriers to the ordered activity plan. Reinforce the approved progression and stop or escalate for concerning symptoms rather than prescribing an unsupervised exercise dose from this study.

Limitations & cautions

• Fatigue was a post hoc secondary outcome measured with trial-specific self-report questionnaires, the intervention was unsupervised, and the four-week intention-to-treat result was marginal at P=0.05. The study does not establish clinical importance, the best activity dose, or safety and benefit for patients outside the trial's surgical population.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 43 prospective cohorts and phase 2 or later trials in neoadjuvant or adjuvant treatment settings.
• Fatigue was more frequent with immune checkpoint inhibitors than placebo, with a risk ratio of 1.21 and a 95% confidence interval from 1.08 to 1.35.
• Patient-reported outcomes showed a small increase in fatigue, with a standardized mean difference of 0.12.
• The chemotherapy comparison was inconclusive, and study-level bias limits confidence about the magnitude and course of fatigue.

Nursing implications

• Assess fatigue with the approved tool and trend its onset, severity, function, sleep, mood, nutrition, and accompanying symptoms across treatment cycles. Escalate new or worsening fatigue for evaluation of treatment toxicity, endocrine effects, anemia, infection, or other causes according to the oncology pathway.

Limitations & cautions

• The included studies spanned different cancers, agents, treatment settings, and fatigue measures. Risk of bias was high because of allocation concealment and open-label designs, the abstract does not define fatigue severity or trajectory consistently, and the comparison with chemotherapy was imprecise.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review screened 2,110 records and included 13 clinical guidance documents.
• Thirty-five recommendations were organized into five nursing-process categories.
• The resulting algorithm aims to standardize assessment, planning, intervention, and follow-up.
• The review developed the algorithm but did not test its feasibility, acceptability, or clinical effects.

Nursing implications

• Offer a private, permission-based opportunity to discuss sexual health, assess symptoms and patient priorities, and document concerns using neutral language. Address needs within role and route pain, bleeding, infection concerns, medication effects, pelvic-health needs, or psychosocial distress to the appropriate clinician.

Limitations & cautions

• The review included guidance documents of high and average methodological quality, was not registered, and produced an algorithm without implementation testing. The abstract does not list all 35 recommendations or show that the pathway improves symptoms, quality of life, or care access.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The prospective randomized study assigned 206 adults to a PICC or implantable port and analyzed 192.
• Major complications occurred in 17.8% with PICCs and 4.9% with ports.
• Ports cost more than PICCs when chemotherapy lasted less than six months.
• Overall quality of life did not differ significantly between groups.

Nursing implications

• Verify the selected device and maintenance plan, assess the site and line function before use, and follow the approved dressing, flushing, access, and infection-prevention procedures. Teach patients to report pain, swelling, redness, drainage, fever, resistance, leakage, or device damage promptly.

Limitations & cautions

• The study was conducted at one center, 14 randomized participants were not included in the analysis, and the abstract does not detail individual complication types or blinding. Costs reflect one health system and may not generalize elsewhere.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The phase 3 trial randomized 241 patients with Barcelona Clinic Liver Cancer stage B disease to sequential TACE-ablation or TACE alone.
• Median progression-free survival was 17.7 months with TACE-ablation and 7.3 months with TACE alone.
• Median overall survival was 88.6 months and 35.1 months, respectively.
• Grade 3 or 4 treatment-related adverse events occurred in 23.2% with combination treatment and 18.3% with TACE alone.

Nursing implications

• For patients receiving an approved TACE-ablation sequence, confirm the treatment plan and baseline assessment, complete ordered post-procedure monitoring, and escalate bleeding, severe pain, fever, hemodynamic change, or worsening hepatic symptoms. Reinforce the scheduled imaging, laboratory, and oncology follow-up plan.

Limitations & cautions

• The trial was open label and conducted at two tertiary centers in China; most participants were men. Results apply to the enrolled population with liver-confined, unresectable stage B hepatocellular carcinoma and should not be generalized to other stages, tumor burdens, or ablation approaches.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 37 randomized trials, including four cluster trials, across the breast-cancer care continuum.
• Pooled analyses found higher diagnostic follow-up compliance and screening mammogram adherence with patient navigation.
• Several apparent benefits did not remain statistically significant after a more conservative adjustment.
• Heterogeneity was substantial and the overall methodological quality was low, so the authors called for stronger trials.

Nursing implications

• When navigation is part of your role, document the unresolved care step, responsible team, patient-reported barrier, and next contact date. Use the organization's approved tracking and escalation process for missed screening, abnormal results, delayed diagnostic resolution, or disconnected treatment follow-up.

Limitations & cautions

• Most pooled outcomes had substantial heterogeneity, with I-squared values from 63.9% to 93.0%, and prediction intervals often included no effect. The authors rated overall methodological quality as low, several outcomes could not be pooled, and some benefits disappeared with conservative statistical adjustment.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 202 participants, with 101 assigned to each treatment sequence.
• Pathologic complete response was 55.4% with chemotherapy-first treatment and 42.57% with the conventional sequence.
• Sphincter preservation, resection margins, and surgical complications were similar between groups.
• The survival analysis was exploratory and immature, so the response difference does not establish a long-term survival benefit.

Nursing implications

• Confirm the current phase and sequence at each handoff, reconcile treatment-specific monitoring and supportive-care plans, and promptly communicate hematologic, urinary, gastrointestinal, or other concerning symptoms. Present pathologic response and survival as separate outcomes during education.

Limitations & cautions

• The trial addressed a resource-limited context and enrolled 202 participants. Overall survival was a secondary exploratory outcome and follow-up was not mature; larger studies with longer follow-up are needed before inferring a survival advantage or broad generalizability.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 52 publications addressing precision-oncology nursing roles, competencies, or education.
• Nursing contributions extended from genomic risk assessment and communication to navigation, service integration, and governance.
• Most identified education emphasized foundational capabilities, with less explicit preparation for advanced interpretive and leadership roles.
• The proposed three-level competency model is a framework and has not been validated as an education or patient-outcome intervention.

Nursing implications

• Clarify which genomic conversations, assessments, and coordination tasks fall within the nurse's verified competency and local role. Use approved patient resources, route interpretive questions to qualified genetics or oncology clinicians, and document education and follow-up needs.

Limitations & cautions

• This was a scoping review that mapped a heterogeneous literature and education landscape rather than evaluating effectiveness. The education search included generative-AI-assisted grey-literature methods, identified program availability may change, and the proposed competency levels require validation before they are used for credentialing or scope decisions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The real-world cohort included 303 patients treated at 18 oncology centers, with 76 patients age 65 or older.
• Response, disease control, treatment modifications, and grade 3 or higher neutropenia were comparable between age groups.
• Chronological age was not independently associated with overall or progression-free survival after adjustment.
• The selected older group and retrospective design limit conclusions about frailer adults or causal treatment effects.

Nursing implications

• Review ordered blood counts and current symptoms before treatment, assess how comorbidities and functional status affect the care plan, and escalate fever, infection concerns, or suspected treatment toxicity promptly. Communicate trends and treatment interruptions so the oncology team can make patient-specific dosing and supportive-care decisions.

Limitations & cautions

• This was a retrospective study of a selected treated population across Central European centers, and only 76 patients were age 65 or older. Age 65 does not capture frailty, selection into treatment may explain apparent similarities, and residual confounding remains. The abstract reports severe neutropenia but does not provide a complete age-stratified adverse-event profile.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The single-center randomized trial enrolled 210 adults aged 65 or older receiving chemotherapy for non-Hodgkin lymphoma.
• Fall incidence among 194 follow-up completers was 7.1% with the preventive nursing program and 19.8% with standard care.
• The intervention group also had better functional-mobility, chemotherapy-completion, and quality-of-life outcomes.
• The 12-week, single-center design and completer analysis limit generalizability.

Nursing implications

• Use the facility's oncology fall-risk process to reassess mobility and treatment-related risks across chemotherapy visits, then individualize prevention measures and document changes. Escalate new weakness, neuropathy, dizziness, falls, or injuries through the oncology team rather than adopting the study protocol without local review.

Limitations & cautions

• The trial was conducted at one center, followed patients for 12 weeks, and reports results for 194 of 210 enrolled participants who completed follow-up. The abstract does not describe allocation concealment, blinding, or every component of the intervention, and the authors call for multicenter, longer-term validation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The network meta-analysis included 54 randomized trials and 10,455 adults receiving chemotherapy.
• Olanzapine-containing regimens improved multiple nausea and vomiting outcomes versus placebo-containing regimens.
• Direct comparisons did not show significant efficacy differences between 10 mg and 5 mg.
• Dose reduction to 5 mg did not clearly reduce sedation, and evidence for 2.5 mg was very limited.

Nursing implications

• Assess both breakthrough nausea or vomiting and sedation when olanzapine is part of an ordered antiemetic regimen. Do not interpret a lower dose as sedation-free, and communicate symptom-control or tolerability concerns to the oncology team rather than changing prophylaxis independently.

Limitations & cautions

• Network estimates combine direct and indirect comparisons across different chemotherapy regimens, emetogenic-risk groups, and antiemetic backbones. The abstract does not report certainty ratings for each comparison. Evidence for 2.5 mg was sparse, and dose reduction from 10 mg to 5 mg did not clearly reduce sedation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 51 women newly diagnosed with breast cancer, and 44 completed follow-up.
• The intervention added six weekly Roy-model nursing sessions to standard psycho-oncology care.
• Psychosocial adjustment improved more in the intervention group over time.
• Resilience also improved, with outcomes followed for three months.

Nursing implications

• Oncology services may consider a structured, theory-guided nursing pathway for early adjustment support while preserving standard psycho-oncology care. The study does not establish one universal session format or demonstrate effects on treatment adherence, symptoms, or longer-term outcomes.

Limitations & cautions

• This was a single-center trial with 51 randomized participants and a per-protocol analysis of 44 completers. Outcomes were self-reported, follow-up lasted three months, and the results do not establish effects on cancer treatment, physical symptoms, adherence, or longer-term mental health.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The six-clinic trial randomized 1,214 adults with advanced solid cancer to digital symptom monitoring plus usual care or usual care alone.
• The intervention combined weekly symptom reports, automated self-management guidance, and nurse follow-up for severe alerts.
• Quality of life and self-efficacy were better maintained over 18 weeks with digital monitoring.
• Fewer analyzed participants had worsening unplanned hospitalization episodes, and mean inpatient days were lower, while emergency-department use was not significantly different.

Nursing implications

• For oncology services considering remote monitoring, the intervention should be understood as weekly reporting plus automated guidance plus a staffed nurse-response workflow. The results do not show that passive symptom collection alone is effective, and they should not be generalized beyond the studied advanced-cancer population without local evaluation.

Limitations & cautions

• The trial was conducted in six Hong Kong palliative clinics among community-dwelling adults with advanced solid cancer who were no longer receiving systemic therapy. Follow-up was 18 weeks, caregivers used the app for many participants, and hospitalization and performance-status results in the abstract were reported for smaller analyzed groups than the 1,214 people randomized.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• At 3 to 4 weeks, more intervention patients were free of both diarrhea and constipation than usual-care patients (53.8% vs 27.5%, p=0.01).
• Freedom from constipation alone was also higher in the intervention group (74.4% vs 45%, p=0.01).
• The program was highly feasible (94.1% recruitment, 98.8% completion) and acceptable (over 80% adopted self-management strategies).
• Gains were sustained at 12 weeks within a sub-sample, and the authors call for a fully powered randomized controlled trial.

Nursing implications

• For oncology nurses, the findings suggest that a structured, nurse-led program of dietary education, self-management coaching, and regular telephone follow-up can help chemotherapy patients manage diarrhea and constipation and is well accepted by patients. Because this was a small pilot, any such program should be pursued through the treating team rather than adopted as established practice.

Limitations & cautions

• This was a single-country pilot randomized trial designed to test feasibility rather than to prove effectiveness, so the sample was small and the 12-week outcomes came from a sub-sample of intervention participants only. The culturally tailored, low-resource design may not transfer directly to other settings, and the authors state that a fully powered randomized controlled trial is still needed.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Honey combined with cryotherapy delayed the onset of radiation-induced oral mucositis (15.58 vs 11.58 days; P = 0.003).
• The incidence of grade II or higher mucositis was lower with the intervention (11.11% vs 33.33%; P = 0.045).
• Severity grading favored the intervention group in both the second week (P = 0.005) and third week (P = 0.014) of treatment.
• The study was small (72 patients, 36 per group) and single-center, and the authors call for further validation.

Nursing implications

• For oncology nurses caring for head and neck cancer patients on chemoradiotherapy, the findings suggest that a structured honey and cryotherapy routine around radiotherapy sessions may postpone and soften oral mucositis, improving comfort and treatment tolerance. Any such protocol should be adopted through the treating team rather than improvised, given the small single-center evidence base.

Limitations & cautions

• This was a single-center prospective study of only 72 patients conducted between July 2021 and May 2022, so the results may not generalize and could reflect local practice. The authors describe the benefit as probable and explicitly call for more comprehensive studies before honey plus cryotherapy is treated as established practice.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• ONS and ASCO jointly published a guideline on managing antineoplastic extravasation, built with GRADE methodology and a systematic review.
• Recommendations address antidote use for vesicants and for irritants with vesicant properties.
• They also address thermal compress application and how long to apply it.
• They call for early surgical referral or specialty escalation for extravasation involving a central venous access device.

Nursing implications

• Know where your unit's extravasation protocol and antidote kit live before a leak happens, and confirm they reflect current ONS/ASCO guidance. Determine whether a leaked agent is a vesicant or an irritant with vesicant properties, apply the correct thermal compress for the recommended duration, and escalate a central venous access device extravasation early rather than waiting.

Limitations & cautions

• As a consensus practice guideline, the strength of individual recommendations depends on evidence that is often limited for a rare event. The abstract names recommendation topics but not specific agents, temperatures, or durations, so the full text must be read before applying any intervention.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The network meta-analysis pooled 49 trials, 24 methods, and 3,887 patients.
• Massage therapy ranked highest for reducing cancer-related fatigue.
• Strengthening exercise ranked lowest in this particular analysis.
• The authors call for larger, higher-quality trials before adopting one approach as best.

Nursing implications

• Assess cancer-related fatigue routinely as a symptom rather than treating it as unavoidable, offer low-risk comfort measures such as massage where appropriate and consistent with the care plan, and avoid presenting any one therapy as proven best given the wide uncertainty.

Limitations & cautions

• Few trials supported each individual therapy, and much of the evidence base used culturally specific modalities, limiting generalizability. The rankings signal promise, not certainty, and do not establish a single recommended program.
• AI-summarized from the linked source. Review the original article before applying to practice.